Skip to main content

Advertisement

Table 4 Associations between vertebral fracture and lung function according to fracture site

From: Cross-sectional associations between prevalent vertebral fracture and pulmonary function in the sixth Tromsø study

  Pulmonary function (mean (SD) or (SE))
  Men Women
  No vertebral fracture (n = 771) Fracture T4-T12 (n = 82) Fracture L1-L4 (n = 39) P T4-T12a P L1-L4a No vertebral fracture (n = 1079) Fracture T4-T12 (n = 94) Fracture L1-L4 (n = 67) P T4-T12a P L1-L4a
FVC% predictedb 98.2 (15.3) 97.0 (17.5) 97.7 (18.1) 0.500 0.856 101.2 (15.8) 104.4 (17.4) 99.0 (18.7) 0.058 0.264
FEV1% predictedb 88.9 (16.9) 85.7 (21.4) 85.3 (21.5) 0.120 0.219 93.0 (17.4) 95.8 (19.5) 89.8 (22.3) 0.145 0.154
FEV1/FVC% predicteda 90.6 (10.8) 87.8 (13.6) 86.8 (11.8) 0.027 0.035 92.0 (9.1) 91.3 (9.6) 89.6 (11.4) 0.505 0.046
Adjustedc values (n = 665) (n = 74) (n = 31)    (n = 800) (n = 60) (n = 44)   
FVC (liter (SE)) 4.22 (0.024) 4.18 (0.073) 4.34 (0.113) 0.569 0.296 2.99 (0.015) 3.10 (0.055) 2.89 (0.066) 0.045 0.141
FEV1 (liter (SE)) 3.08 (0.021) 3.01 (0.063) 3.16 (0.098) 0.292 0.415 2.21 (0.013) 2.32 (0.048) 2.14 (0.057) 0.032 0.212
FEV1/FVC (SE) 0.73 (0.003) 0.72 (0.009) 0.73 (0.014) 0.240 0.857 0.74 (0.002) 0.75 (0.008) 0.74 (0.010) 0.405 0.960
  1. The Tromsø Study 2007-08.
  2. aVersus no fracture.
  3. bEquation from Langhammer et al. [27].
  4. cAdjusted for age, smoking habits, height, weight, physical inactivity, cardiovascular disease, lung disease, corticosteroids, hip BMD, hormones for menopause (women).